Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis
- 1 March 2003
- journal article
- clinical trial
- Published by Springer Nature in Genes & Immunity
- Vol. 4 (2), 147-152
- https://doi.org/10.1038/sj.gene.6363946
Abstract
Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system characterized by progressive neurological dysfunction. No curative therapy is currently available, and approximately 80–90% of afflicted individuals are ultimately disabled. Interferon beta (IFNβ) has been shown to decrease clinical relapses, reduce brain disease activity, and possibly slow progression of disability. However, the overall effect of treatment is partial and a substantial number of patients are considered poor or nonresponders. For this report, we tested the pharmacogenomic effects of eight polymorphisms in the interferon receptor genes (IFNAR1 and IFNAR2) in a group of 147 patients undergoing open-label IFNβ therapy. Overall, no significant differences in the distribution of responders and nonresponders, classified based on prospectively acquired primary and secondary clinical end points, were observed when stratified by any of the studied IFNAR gene polymorphisms. A trend detected with a single nucleotide polymorphism SNP 16469 (A/T) located at the third intron of the IFNAR1 gene, suggesting modest association with relapse-free status, will require confirmation in an independent data set. In addition, no significant association was observed of any of the IFNAR gene polymorphisms with susceptibility to MS, as studied by a family-based association analysis.Keywords
This publication has 28 references indexed in Scilit:
- The genetic basis of variability in drug responsesNature Reviews Drug Discovery, 2002
- Interferon-β in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?Current Opinion in Neurology, 2001
- Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4Journal of Neuroimmunology, 2000
- RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1bJournal of Neuroimmunology, 2000
- A Test for Linkage and Association in General Pedigrees: The Pedigree Disequilibrium TestAmerican Journal of Human Genetics, 2000
- Transmission/Disequilibrium Tests for Extended Marker HaplotypesAmerican Journal of Human Genetics, 1999
- The Type I Interferon Receptor: Structure, Function, and Evolution of a Family BusinessJournal of Interferon & Cytokine Research, 1999
- The human interferon $alpha;/$beta; receptor: Characterization and molecular cloningCell, 1994
- Linkage mapping of highly informative DNA polymorphisms within the human interferon-α receptor gene on chromosome 21Genomics, 1991
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983